CSIR move to develop low-cost TB drugs
Its Open Source Drug Discovery (OSDD) initiative to develop an anti-TB molecule would soon go for first phase clinical trial
Its Open Source Drug Discovery (OSDD) initiative to develop an anti-TB molecule would soon go for first phase clinical trial
It will put in place a regulatory framework for pricing of drugs to ensure their availability at reasonable prices […]
Now, irrespective of the brand, all domestically-produced insulin would cost between Rs135-145 per packet New Delhi: The Government of […]
Hyderabad -based GVK Biosciences, has set up the India’s largest isotope labelling facility in the city. This Good Laboratory Practice […]
A leading MNC in medical technology, Trivitron Healthcare has announced its strategic partnership with Diasorin Group, a global leader in […]
From 1st November, doctors in Kerala will only prescribe generic drugs. Patients in government medical colleges and hospitals in Thiruvananthapuram, […]
The software has been developed by Gujarat FDCA and helps track substandard drugs with a view to ensure safety of consumers
i2india Ventures, a technology major, is expanding the availability of its lung-care device known as the LungFlute. The innovative medical […]
GE Healthcare, the healthcare business of GE (NYSE: GE) has introduced KUBio, an innovative off-the-shelf, modular factory designed to save […]
Dutch electronics major Philips plans to expand its global Research &Development centre in Bangalore, Philips Innovation Campus to focus on […]
Health Level Seven International (HL7), one of the leaders in developing interoperability standards for healthcare IT has announced its decision […]
A new recommendation has come in for the Indian drug companies. Most Indian drug companies that were penalised for violating […]
Indian Angel Network (IAN) and India Innovation Fund announced today an undisclosed investment in Consure Medical; a Delhi based company […]